Support MI up for updates Subscribe up for updates
About Research Events Centers Newsroom Currency of Ideas
Global Conference 2013 | Program by Track Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013 Global Conference 2013
Register Online Now

Program - By Health Track:

Monday, April 29, 2013

  8:00 AM - 9:15 AM

The Promise of the Bioscience Century

Eric Cantor , U.S. Congressman and Majority Leader
Paul Chew , Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs, Sanofi
Margaret Hamburg , Commissioner, U.S. Food and Drug Administration
Bernard Harris Jr. , Founder and President, Harris Foundation; CEO and Managing Director, Vesalius Ventures, Inc.
Geoffrey Ling , Deputy Director, Defense Sciences Office, DARPA

Michael Milken , Chairman, Milken Institute

America's investment in bioscience, especially through the National Science Foundation and the National Institutes of Health, accelerated for several years beginning in 1998. Today, we're reaping the return on that investment as what once seemed impossible becomes routine. Precision medicine is reducing suffering and deaths, and processes that once took years and cost millions - think sequencing the human genome - get faster and cheaper by the day. But those advances are merely a prologue. We're at the dawn of a scientific revolution that will save, extend and improve the quality of people's lives across the planet while easing the tremendous economic burden of health care. Moreover, bioscience holds promise for solving seemingly intractable global challenges related to energy, access to clean water and sustainable food production. How do we quicken this work? Who will fund it? And how can the participants in the bioscience ecosystem work together more effectively?

Read the blog post

  9:30 AM - 10:30 AM

Magic Johnson and David Ho: Winning the Battle Against AIDS

David Ho , Scientific Director and CEO, Aaron Diamond AIDS Research Center; Professor, The Rockefeller University
Earvin (Magic) Johnson , Chairman and CEO, Magic Johnson Enterprises; NBA Hall of Famer; Co-Owner, Los Angeles Dodgers

Al Michaels , Sportscaster, NBC Sports

Research and treatment, outreach and education - these are the keys to defeating the worldwide menace of AIDS. Basketball great Earvin (Magic) Johnson, still vital 21 years after his HIV diagnosis, and renowned researcher Dr. David Ho will bring the two sides together at this event. The pair will discuss the advances that have turned what was once a lethal infection into something akin to a manageable chronic illness. Magic is sure to share his personal story - his experience living with the condition and his commitment to awareness and testing. The focus, however, will be on the future, including the next wave of treatments, the search for a vaccine and making progress in educating communities that are most vulnerable to the disease.

Read the blog post

  9:30 AM - 10:30 AM

How Leading-Edge Corporate Health Solutions Create a Healthier Bottom Line

Kent Bradley , Senior Vice President and Chief Medical Officer, Safeway Inc.
Lynn Goldman , Dean, School of Public Health and Health Services, George Washington University
David Kirchhoff , CEO, Weight Watchers International Inc.
Richard Merkin , CEO and Founder, Heritage Group; Board Member, FasterCures
Sue Siegel , CEO, healthymagination, GE

Bianna Golodryga , Co-Anchor, "Good Morning America Weekend Edition," and Business Correspondent, ABC News

Creating a culture of health. Wellness enhances productivity. Engaged employees improve well-being. These are concepts we can agree with, but we puzzle over how they are put into practice at other companies, and not our own. There are many ideas on how to improve employee health and ultimately reduce costs, but for real change to occur, a sound idea must be well-executed. A promising idea may fall flat in the implementation, while a bad idea may gain traction as a result of strong execution -- neither will lead to meaningful, measurable change. Join us as we explore evidence-based initiatives with quantifiable results for a healthier bottom line.

Read the blog post

  10:45 AM - 11:45 AM

Precision Medicine, Custom Cures

Christopher Austin , Director, National Center for Advancing Translational Sciences, National Institutes of Health
Retta Beery , Patient Advocate and Speaker, Beerys Dystonia Support Site
George Church , Robert Winthrop Professor of Genetics, Harvard Medical School
James Greenwood , President and CEO, Biotechnology Industry Organization
Michael Pellini , President and CEO, Foundation Medicine

Margaret Anderson , Executive Director, FasterCures

More than a decade after the human genome was sequenced, we are starting to see the fruits of countless incremental advances in clinical genomics and disease biology. From techniques that enable doctors to test tumor samples for hundreds of mutations to activating the immune system to fight cancer and using drugs intended for one indication to successfully treat another, truly individualized success stories are an exciting feature of modern medicine. Could the information revealed by sequencing your genome be the secret weapon against deadly diseases? What tools can turn genomic data into crucial medical information on a large scale? This panel will discuss the advances that have been made, those yet to come, and how every patient can gain access to the most individualized medicine possible.

Read the blog post

  2:15 PM - 3:15 PM

Living to 1,000: Impossible or Within Reach?

Lorelei Mucci , Associate Professor of Epidemiology, Harvard School of Public Health
Gary Small , Parlow-Solomon Professor on Aging and Professor of Psychiatry, UCLA; Director, UCLA Longevity Center, Semel Institute for Neuroscience and Human Behavior
Harvey Spevak , CEO, Equinox

Howard Soule , Senior Fellow, Milken Institute; Chief Science Officer, Prostate Cancer Foundation

Some say the first person who will live to be 1,000 years old is alive today. Whether true or not, there's no disputing that humans are living longer than before, thanks to science, public health systems, diet and a better understanding of what it takes to thrive. The implications - for business, government and society - are profound. This panel will examine the latest research on aging and related scientific and medical advances while outlining proactive steps toward a longer life span -- maybe much longer.

  2:15 PM - 4:15 PM

A Food Movement to Nourish the Nation (By invitation only)

Rory Eakin , Founder and Chief Operating Officer, CircleUp
Louise Holland , Deputy to Jamie Oliver, Jamie Oliver Food Foundation
Mary Lee , Deputy Director, PolicyLink
Kelly Meyer , Co-Founder, American Heart Association Teaching Gardens
Walter Robb , Co-CEO, Whole Foods Market
Wendelin Slusser , Associate Clinical Professor, Mattel Children's Hospital, UCLA Schools of Medicine and Public Health; Leader, Healthy Diet and Nutrition Transformation, UCLA Chancellor's Healthy Campus Initiative
Kimberly Stitzel , Vice President, Nutrition and Obesity Strategies, American Heart Association
Daniel Tellalian , Principal, Emerging Markets, Inc.

Lawrence Soler , President and CEO, Partnership for a Healthier America

A food movement is germinating. Food has taken center stage in disease prevention and the future success of our children. Groups are mobilizing to advocate for healthier food policies, and new business models aim to expand access to low-cost, healthy foods. Gardening and nutrition are being incorporated into school curriculums nationwide. Forward-thinking organizations see good food in the workplace as an investment in their people. What is the food movement's role in improving health and nutrition? What kind of human and financial capital will be needed to achieve its goals? How can business, philanthropy and government work together? This session will assemble medical and nutrition experts and business, government and community leaders to advance the effort to ensure a healthier future.

  3:30 PM - 4:30 PM

Mobilizing the Immune System in the Battle Against Cancer

Arie Belldegrun , Executive Chairman, Kite Pharma, Inc.; Director, UCLA Institute of Urologic Oncology
Michael Giordano , Senior Vice President, Head of Development, Oncology and Immunoscience, Bristol-Myers Squibb
Jeff Rowbottom , Managing Director, Kohlberg, Kravis, Roberts
Suzanne Topalian , Professor of Surgery and Oncology, Johns Hopkins University; Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center

Louise Perkins , Chief Science Officer, Melanoma Research Alliance

The immune system recognizes and attacks a diverse array of potential enemies. In fact, it has the remarkable ability to react to any molecule in the universe. Cancer cells should "look" like invaders to the immune system, but unfortunately this natural defense is imperfect, and tumor cells may escape identification and go on to cause cancer. The connection between cancer and the immune system was first uncovered nearly 100 years ago. Since then, researchers have been working to learn why the system does not eliminate cancer and, more importantly, how to enable it to conquer this menace. After decades of research, so-called immunotherapies have been developed. Now, cancer patients who previously had just months to live have been living many years after receiving immune-based treatment. This panel will discuss the promise of modifying the immune system to treat and cure cancer.

  3:30 PM - 4:30 PM

Investing in Our Future: Best Cities for Successful Aging

Laura Carstensen , Professor of Psychology and Founding Director, Stanford Center on Longevity
Henry Cisneros , Executive Chairman, City View; former Secretary, U.S. Department of Housing and Urban Development; former San Antonio Mayor
Marc Freedman , CEO,
Nancy LeaMond , Executive Vice President, State and National Group, AARP

Joseph Coughlin , Director, Massachusetts Institute of Technology AgeLab

The best cities of the future will provide us with the opportunity to age successfully in place - to remain healthy, active, enriched and engaged. With an aging U.S. population and a changing demographic mix, cities that plan, respond and invest wisely will thrive. Those that don't will wither. What will the city of the future look like? We'll need mixed-use housing, well-designed public transit, educational opportunities to keep us current and proficient, a wide range of primary and encore career opportunities to engage us well beyond traditional retirement age and health care that's effectively delivered. Which cities are headed in the right direction, which aren't, and why? And what can each of us - business and civic leaders, investors, philanthropists, educators, the media - do to create a brighter city future for our parents, our neighbors, our kids and ourselves?

Tuesday, April 30, 2013

  10:45 AM - 11:45 AM

Financing the Future of Bioscience and Pharma

Jodi Black , Deputy Director, Division of Extramural Research Activities, NHLBI, National Institutes of Health
Louis DeGennaro , Executive Vice President and Chief Mission Officer, Leukemia & Lymphoma Society
Rajiv Kaul , Portfolio Manager, Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments
Matthew Perry , Portfolio Manager, BVF Partners L.P
Greg Simon , CEO, Poliwogg; Board Member, FasterCures

Melissa Stevens , Deputy Executive Director, FasterCures

High-risk, long-term investments are needed to turn medical innovations into lifesaving therapies. However, an industry-wide funding gap for early-stage drug development coupled with a retreat by venture investors from all but late-stage life sciences have created the need for new inventive, sustainable funding models. In the last year, many of these approaches -- from novel public-private partnerships to highly leveragable venture philanthropy investments to a new breed of institutional fund managers -- have come into their own, with early data supporting an optimistic view of what's ahead. There is also a growing movement to apply nontraditional models such as crowdfunding as a disruptive force in biotech. How are these models improving the risk-return ratio for early-stage research, making it a more attractive opportunity? What are the pitfalls? How does the involvement of philanthropic and/or government funding create leverage and attract greater private investment?

  3:45 PM - 4:45 PM

Life Science R&D Financing: How Can Capital Collaborate? (By invitation only)

Louis DeGennaro , Executive Vice President and Chief Mission Officer, Leukemia & Lymphoma Society
Earle Mack , Senior Partner, Mack Co.; former U.S. Ambassador to Finland
Bernard Munos , Founder, Innothink; Senior Fellow, FasterCures
Melissa Stevens , Deputy Executive Director, FasterCures

In medical research, we talk about breaking down the silos among scientific laboratories, institutions and disciplines. Shouldn't we be doing the same with R&D financing? Our panel will discuss new markets and mechanisms that can help capital collaborate while managing risk. When the innovation baton is passed from academia, how do we ensure there is a finance partner to run with it? How can we marry the mission-driven money from foundations with the return-seeking resources of traditional investors? What new players, such as endowments and family offices, should participate?

Wednesday, May 1, 2013

  8:30 AM - 9:45 AM

Stopping Alzheimer's: Personal, Economic and Policy Imperatives

Neil de Crescenzo , Senior Vice President and General Manager of Health Sciences, Oracle
Robert Hormats , Under Secretary, Economic Growth, Energy, and the Environment, U.S. Department of State
Sue Siegel , CEO, healthymagination, GE
George Vradenburg , Chairman, USAgainstAlzheimer's
Anne Whitaker , President, North America Pharmaceuticals, Sanofi

Cecilia Arradaza , Director, Communications and Policy, FasterCures

Alzheimer's disease and dementia is a global crisis that requires a global solution. It is estimated that 36 million people worldwide suffer from dementia today, a number that is likely to spike to 115 million by 2050. According to Alzheimer's Disease International, the current global cost of care exceeds $600 billion annually. Yet this seminal public health issue promises even more profound fiscal and social impact in the future. But how do we get to meaningful solutions? What partnerships, research investments, business models and policy changes must be put in place? Panelists from diverse backgrounds will share insights about grappling with the realities of Alzheimer's for patients, caregivers, the health care system and economic productivity.

  10:00 AM - 11:00 AM

Bioscience Discoveries That Will Blow Your Mind

Jack Andraka , Student Inventor, Scientist and Cancer Researcher; 2012 Intel Science Fair Grand Prize Winner
David Baltimore , Nobel Laureate, Medicine, 1975; Robert Andrews Millikan Professor of Biology, California Institute of Technology
Francis Collins , Director, National Institutes of Health
Tejal Desai , Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco
Aydogan Ozcan , Associate Professor of Electrical Engineering and Bioengineering, University of California, Los Angeles

Margaret Anderson , Executive Director, FasterCures

Thanks to the amazing scientific breakthroughs of the past century, average life expectancy on the planet has more than doubled. In the last 25 years alone, the overall death rate for cancer in the United States has declined 20 percent - averting 1.2 million deaths. We've developed vaccines to prevent tuberculosis, hepatitis, polio and, possibly soon, HIV. Advances in stem-cell therapy have enabled us to literally rebuild body parts, and the science now exists to convert our cell phones into microscopes. What wonders are currently being cooked up in R&D labs? Join us for sneak previews that are sure to leave you buzzing.

Read the blog post

  11:15 AM - 12:15 PM

How Improved Health and Longer Lives Drive Global Prosperity

Thomas Frieden , Director, U.S. Centers for Disease Control and Prevention
Jonathan Gluck , Senior Executive, Heritage Provider Network, Inc.
Carole Roan Gresenz , Jacobs Professor, Department of Health Systems Administration, Georgetown University; Adjunct Senior Economist, RAND Corp.
Michael Harsh , Vice President and Chief Technology Officer, GE Healthcare
Peter Margolis , Professor of Pediatrics, University of Cincinnati School of Medicine; Director of Research, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center

Ceci Connolly , Managing Director, Health Research Institute, PricewaterhouseCoopers

Improvements in health that have given us longer, more productive lives are also responsible for as much as half of the world economy's expansion over the last two centuries. The savings that come with earlier detection and prevention of disease, more effective therapies and diagnostics and more efficient delivery of care pay large social and economic dividends. This panel will explore innovations in public health, research and medical care that are improving our productivity and economic outlook as well as our vitality. Among the topics our experts will address: reducing the time and cost of developing treatments, increasing transparency in the quality and price of health services and making best use of big data and new technology to improve decision-making.

  11:15 AM - 12:15 PM

Impatient Patients: How Disease Organizations Are Accelerating Research

Debra Black , Co-Founder and Chair, Melanoma Research Alliance
Louis DeGennaro , Executive Vice President and Chief Mission Officer, Leukemia & Lymphoma Society
Gordon Gund , Co-Founder and Chairman, Foundation Fighting Blindness
Jonathan Simons , President and CEO, Prostate Cancer Foundation; Senior Fellow, Milken Institute
John Walsh , Co-Founder, President and CEO, Alpha-1 Foundation

Margaret Anderson , Executive Director, FasterCures

TRAIN, The Research Acceleration and Innovation Network of FasterCures, has worked for the past decade to speed medical advances by connecting more than 50 disease-specific organizations and sharing their best practices. This is lifting barriers to progress in a system where it takes an average of 15 years to translate laboratory breakthroughs into therapies - an eternity to patients with life-threatening diseases and to their families. Disease organizations represent a small fraction of overall medical research spending but play an outsize role in fostering innovative R&D models and supporting high-risk/high-reward research often abandoned by government and industry. Join FasterCures Executive Director Margaret Anderson and TRAIN members as they discuss the enormous power patients have when they work together to accelerate and transform medical research.

  12:30 PM - 2:30 PM

Lunch Panel: A Cure for What Ails Us: Celebrating the Impact of Science

Nancy Brown , CEO, American Heart Association
Francis Collins , Director, National Institutes of Health
Thomas Frieden , Director, U.S. Centers for Disease Control and Prevention
Andrew von Eschenbach , President, Samaritan Health Initiatives Inc.; former Commissioner, U.S. Food and Drug Administration; former Director, National Cancer Institute

Michael Milken , Chairman, Milken Institute

Reasonable people disagree about the specifics of reforming America's complicated system of health care and insurance, but there's no doubt that the best way to cut costs is to prevent people from getting sick in the first place, or to cure them when they fall ill. In an aging nation, nothing would have a greater impact on the federal budget. Bioscience has produced an estimated half of all economic growth for a century by increasing productivity and creating jobs while preventing disease and extending lives. But the best is yet to come: We're at the dawn of a scientific revolution that will reduce care costs and serve as the top driver of economic growth - all while saving, lengthening and improving the quality of lives across the planet. A group of U.S. health leaders joins Institute Chairman Mike Milken for a discussion of the future.

  2:45 PM - 3:45 PM

Longevity Is Opportunity: Riding the Demographic Wave

Pinchas Cohen , Dean, University of Southern California Davis School of Gerontology
Michael Hodin , Executive Director, Global Coalition on Aging
Dan Houston , President, Retirement, Insurance and Financial Services, Principal Financial Group
Paul Irving , President, Milken Institute

Jody Holtzman , Senior Vice President, Thought Leadership, AARP

We hear daily about the burden of entitlements, the inadequacy of pensions, the rising costs of health care and the challenges of disease. These realities are daunting, to be sure, but they mask another perspective. The aging of our population - the demographic wave - is about much more than bad news. This seismic shift will change health care, jobs, education, housing, transportation, technology, travel, consumer products and entertainment. It will create new stages of life and new expectations for our mature years. Tackling these burdens and realizing these opportunities will require insight and innovation in both the public and private sectors. An emerging longevity market will reveal opportunities for business leaders and investors to capitalize and achieve breakthrough results. In this session, a group of visionary thinkers describe the issues and the possibilities in the years to come.

  2:45 PM - 3:45 PM

The Role of Universities in Accelerating Bioscience Research

David Baltimore , Nobel Laureate, Medicine, 1975; Robert Andrews Millikan Professor of Biology, California Institute of Technology
Joel Burdick , Professor of Mechanical Engineering and Professor of Bioengineering, California Institute of Technology
James Economou , Vice Chancellor for Research, University of California, Los Angeles
Michael Quick , Executive Vice Provost and Professor of Biological Sciences, University of Southern California
Owen Witte , Director, Broad Stem Cell Research Center, University of California, Los Angeles; Distinguished Professor of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles

Stephen Mayo , William K. Bowes Jr. Foundation Chair, Division of Biology, and Bren Professor of Biology and Chemistry, California Institute of Technology

Research in bioscience has been transformed in the last decade, becoming tightly linked to other fields ranging from chemistry, engineering and bioengineering to physics, nanoscience and applied sciences. The intersection of these core disciplines is leading to discoveries that have global impact. Universities are increasingly creating partnerships among these diverse areas to accelerate medical science and change how we think about treating complex health issues in the 21st century. Our panel of leaders in research will examine how these connections are being made and their salutary results.

Global Conference 2013 home
By Day   Sun | Mon | Tue | Wed
July 2014
Jul 29
Developments in Private Capital Markets
Milken Institute Center for Financial Markets, Washington, DC
August 2014
Aug 5
Forum: Creativity, Inc.
Santa Monica
September 2014
Sep 18
Asia Summit
October 2014
View All Events
Search all Videos
MI Video Highlight
Global Conference 2014
Leaders on Leadership: Howard Marks, Janet Napolitano, Steve Wynn and Michael Milken on long-term thinking in business, government, education – and life.
Download Milken Institute
Events Brochure
About Us
  Download Annual Report
  Our Team



  Global Conference
  Partnering for Cures
  State of the State
  Asia / California / London
  Young Leaders

  Latest News
  News Videos
  Press Releases

    Financial Markets
    Israel Center
    Public Health


  Financial Innovations Labs
  Milken Institute Review
   Amazon Apps
   App Store
  Research Reports
  Search All Publications
Support MI
  Strategic Partners

Follow Us
  iTunes U

Related Sites
  Partnering For Cures
  Celebration of Science
  Chairman's Corner
  Melanoma Research Alliance

©2014 Milken Institute